Current and historical daily PE Ratio for BrightPath Biotherapeutics Co Ltd (
) from 2015 to May 14 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. BrightPath Biotherapeutics stock (TSE:4594) PE ratio as of May 14 2024 is 0.
More Details
BrightPath Biotherapeutics Co Ltd (TSE:4594) PE Ratio (TTM) Chart
BrightPath Biotherapeutics Co Ltd (TSE:4594) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1216
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| BrightPath Biotherapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-14 | At Loss | 2024-03-06 | At Loss |
| 2024-05-13 | At Loss | 2024-03-05 | At Loss |
| 2024-05-10 | At Loss | 2024-03-04 | At Loss |
| 2024-05-09 | At Loss | 2024-03-01 | At Loss |
| 2024-05-08 | At Loss | 2024-02-29 | At Loss |
| 2024-05-07 | At Loss | 2024-02-28 | At Loss |
| 2024-05-02 | At Loss | 2024-02-27 | At Loss |
| 2024-05-01 | At Loss | 2024-02-26 | At Loss |
| 2024-04-30 | At Loss | 2024-02-22 | At Loss |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-16 | At Loss |
| 2024-04-22 | At Loss | 2024-02-15 | At Loss |
| 2024-04-19 | At Loss | 2024-02-14 | At Loss |
| 2024-04-18 | At Loss | 2024-02-13 | At Loss |
| 2024-04-17 | At Loss | 2024-02-09 | At Loss |
| 2024-04-16 | At Loss | 2024-02-08 | At Loss |
| 2024-04-15 | At Loss | 2024-02-07 | At Loss |
| 2024-04-12 | At Loss | 2024-02-06 | At Loss |
| 2024-04-11 | At Loss | 2024-02-05 | At Loss |
| 2024-04-10 | At Loss | 2024-02-02 | At Loss |
| 2024-04-09 | At Loss | 2024-02-01 | At Loss |
| 2024-04-08 | At Loss | 2024-01-31 | At Loss |
| 2024-04-05 | At Loss | 2024-01-30 | At Loss |
| 2024-04-04 | At Loss | 2024-01-29 | At Loss |
| 2024-04-03 | At Loss | 2024-01-26 | At Loss |
| 2024-04-02 | At Loss | 2024-01-25 | At Loss |
| 2024-04-01 | At Loss | 2024-01-24 | At Loss |
| 2024-03-29 | At Loss | 2024-01-23 | At Loss |
| 2024-03-28 | At Loss | 2024-01-22 | At Loss |
| 2024-03-27 | At Loss | 2024-01-19 | At Loss |
| 2024-03-26 | At Loss | 2024-01-18 | At Loss |
| 2024-03-25 | At Loss | 2024-01-17 | At Loss |
| 2024-03-22 | At Loss | 2024-01-16 | At Loss |
| 2024-03-21 | At Loss | 2024-01-15 | At Loss |
| 2024-03-19 | At Loss | 2024-01-12 | At Loss |
| 2024-03-18 | At Loss | 2024-01-11 | At Loss |
| 2024-03-15 | At Loss | 2024-01-10 | At Loss |
| 2024-03-14 | At Loss | 2024-01-09 | At Loss |
| 2024-03-13 | At Loss | 2024-01-05 | At Loss |
| 2024-03-12 | At Loss | 2024-01-04 | At Loss |
| 2024-03-11 | At Loss | 2023-12-29 | At Loss |
| 2024-03-08 | At Loss | 2023-12-28 | At Loss |
| 2024-03-07 | At Loss | 2023-12-27 | At Loss |
BrightPath Biotherapeutics Co Ltd (TSE:4594) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
BrightPath Biotherapeutics Co Ltd
ISIN : JP3274140007
Description
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers